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Abstract
 
The subset of dendritic cells (DCs) and the nature of the signal inducing DC maturation deter-
mine the capacity of DCs to generate polarized immune responses. In this study, we show that
the ability of human monocyte-derived DCs (myeloid DC
 
1
 
) to promote T helper type 1 (Th1)
or Th2 differentiation was also found to be critically dependent on stimulator/responder ratio.
 
At a low ratio (1:300), mature DCs that have been differentiated after inflammatory (
 
Staphylo-
coccus aureus 
 
Cowan 1 or lipopolysaccharide) or T cell–dependent (CD40 ligand) stimulation
induced naive T cells to become Th2 (interleukin [IL]-4
 
1
 
, IL-5
 
1
 
, interferon 
 
g
 
) effectors. Th2
differentiation was dependent on B7–CD28 costimulation and enhanced by OX40–OX40
ligand interactions. However, high DC/T cell ratio (1:4) favored a mixed Th1/Th2 cell devel-
opment. Thus, the fact that the same DC lineage stimulates polarized Th1 or Th2 responses
may be relevant since it allows the antigen-presenting cells to initiate an appropriate response
for the signal received at the peripheral sites. Controlling the number and the rate of DC mi-
gration to the T cell areas in lymphoid tissues may be important for the therapeutic use of DCs.
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Introduction
 
The differentiation of naive T cells into Th1 or Th2 effec-
tors is determined by the cytokine environment (IL-12
versus IL-4), the nature and the strength of the T cell re-
ceptor–mediated signal, the genetic background, and the
type and the activation state of the dendritic cells (DCs)
 
1
 
(1–4). Two distinct lineages of human and mouse DCs
have been described: myeloid and lymphoid DCs (5, 6). In
rodents, myeloid DCs promote Th2 differentiation in vivo
and in vitro (7, 8), whereas lymphoid DCs, the major pro-
ducers of IL-12, are involved in the initiation and mainte-
nance of Th1 responses. In humans, monocyte-derived
DCs (DC
 
1
 
) reportedly induce Th1 cells (9), and the plas-
macytoid DCs (DC
 
2
 
) do not produce IL-12, elicit Th2 re-
sponses, and are the major source of IFN-
 
a
 
 (10, 11).
The ability of monocytes to differentiate in vitro into
DCs under physiological conditions (12) has now been
confirmed in vivo (13); monocytes that phagocytosed sub-
cutaneously injected fluorescent micropheres, migrate to
the lymph nodes and differentiate into DCs (13). It also ap-
pears that the nature of the maturation signals received by
monocyte-derived immature DCs at the peripheral sites as
well as the type of locally released inflammatory mediators
are critical to polarize the immune response (14, 15). A rel-
evant question to ask is whether myeloid-derived imma-
ture DCs (iDCs), the sentinels of the immune system lo-
cated at sites of antigen entry (i.e., in nonlymphoid tissues),
may keep the flexibility to trigger either a Th1 or a Th2 re-
sponse after the encounter with an invading pathogen.
Here we show that human DC
 
1
 
 may indeed trigger the de-
velopment of naive T cells into Th2 effectors, provided
that they display a mature phenotype (high level of costim-
ulatory molecules) and are cultured with naive T cells at a
low density (1:300) DC/T cell ratio.
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Abbreviations used in this paper:
 
 CTLA, cytolytic T lymphocyte–associ-
ated Ag; DC, dendritic cell; DC
 
1
 
, human monocyte-derived DC; DC
 
2
 
,
plasmacytoid DC; iDC, immature DC; mDC, mature DC; SAC, 
 
Staphy-
lococcus aureus 
 
Cowan 1. 
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Materials and Methods
 
Generation of Monocyte-derived iDCs and Mature DCs. 
 
PBMCs
and monocytes were isolated as described (16). To generate iDCs,
monocytes were cultured for 1 h in RPMI 1640 with 10 mM
Hepes, 2 mM 
 
l
 
-glutamine, 100 IU penicillin G, and 100 
 
m
 
g/ml
streptomycin. Nonadherent cells were removed, and after washing
adherent cells were cultured for 6 d with GM-CSF (25 ng/ml) and
IL-4 (25 ng/ml) in complete RPMI 1640 medium supplemented
with 10% fetal bovine serum. Some iDCs were prepared using dif-
ferent GM-CSF/IL-4 ratios (10:100; 5:200 ng/ml) with identical
results. Mature DCs (mDCs) were generated by stimulating iDCs
in complete medium containing GM-CSF and IL-4 for an addi-
tional 2 d with: 
 
Staphylococcus aureaus
 
 Cowan 1 strain (SAC, 0.01%
vol/vol) (Pansorbin; Calbiochem-Novabiochem); SAC plus IFN-
 
g
 
(500 U/ml); L-CD40L transfectants (1.25 
 
3
 
 10
 
6
 
/well; provided
by Dr. J. Banchereau, Schering-Plough, Dardilly, France); IL-1 (1
ng/ml) plus TNF-
 
a
 
 (10 ng/ml); LPS (1 
 
m
 
g/ml) (from 
 
Escherichia
coli
 
 serotype 0111:B4; Sigma-Aldrich); LPS plus IFN-
 
g
 
 or IFN-
 
g
 
for 24 h followed by LPS stimulation for 48 h (
 
g
 
-primed LPS).
Phenotype of different mDCs was analyzed using PE-conjugated
anti-CD83, -CD40, -CD80, -CD86, and anti–HLA-DR mAbs
(ID Labs). The mDC preparations contained 
 
,
 
1% CD14
 
1
 
, CD3
 
1
 
,
CD20
 
1
 
, and CD56
 
1
 
 
 
cells.
 
Purification of Human Naive T Cells and DC–T Cell Cocul-
tures.
 
Naive CD4
 
1
 
 T cells were isolated from umbilical cord
blood of healthy neonates as described (16). In brief, mononu-
clear cells were obtained by centrifugation on Lymphoprep (Ny-
comed Pharma As) and were treated with 
 
l
 
-leucine methyl ester
to remove monocytes and NK cells. Cell preparation was en-
riched in T cells by E-rosetting and CD4
 
1
 
 T cells were obtained
by treating rosette-forming cells with Lympho-kwik T helper
(One Lambda). The resulting populations were 
 
.
 
98% viable
(trypan blue dye exclusion); 
 
.
 
98% CD3
 
1
 
, CD4
 
1
 
CD8
 
2
 
, and
CD45RA
 
1
 
; and contained no detectable CD45RO
 
hi
 
, CD25
 
1
 
,
CD19
 
1
 
, and CD56
 
1
 
 cells. Primary MLRs were conducted in
96-well U-bottomed tissue culture plates by adding mitomycin
C–treated mDCs to 2.5 
 
3
 
 10
 
5
 
 allogeneic CD4
 
1
 
 T cells in 250 
 
m
 
l
complete culture medium at 1:4 and 1:300 stimulator (DCs)/re-
sponder (T cells) ratio. Some cultures were supplemented with
neutralizing Abs to block endogenous cytokines: anti–IL-4 mAb
clone 8F12 (5 
 
m
 
g/ml) plus anti-IL-4R mAb (5
 
m
 
g/ml) (R&D
Systems); anti–IL-12 mAb (clone 8.6, 10 
 
m
 
g/ml; Dr. M. Gately,
Hoffmann-La Roche, Nutley, NJ), or isotype-matched IgG; or
were supplemented with neutralizing anti-CD40L (clone M92;
Immunex), anti-OX40L mAb (clone 5A8, 10 
 
m
 
g/ml [15]), nor-
mal human FcIg, or CTLA-4–Fc (5 
 
m
 
g/ml; P.S. Linsley, Bristol-
Myers, Princetown, NY). After 4 d of culture, 150 
 
m
 
l of culture
 
supernatant was replaced with fresh medium containing 100 U/ml
of IL-2. On days 6 and 8, cultures were split and expanded in
the presence of 50 U/ml of IL-2. After 7–10 d of IL-2 expansion,
cells were washed, counted, and viable cells were tested for cy-
tokine production. T cells (10
 
6
 
/ml) were restimulated with anti-
CD3 mAb (UCHT1, 200 ng/ml; P. Beverly, University College
and Middlesex School of Medicine, London, UK) immobilized
on mitomycin C–treated CD32-B7 L double transfectant cells
prepared as described (17). Some T cells were restimulated with
PMA (10 ng/ml) and ionomycin (1 
 
m
 
g/ml). 24 or 48 h after re-
stimulation, the cell-free supernatants were collected and frozen
at 
 
2
 
20
 
8
 
C until assayed. Note that in some experiments, DC–T
cell cocultures were performed for 6–7 d, washed, and imme-
diately restimulated with anti-CD3 immobilized on mitomycin
C–treated CD32-B7 L double transfectant cells.
 
Flow Cytometry Analysis of Intracellular Cytokines.
 
After IL-2
expansion, T cells (10
 
6
 
/ml) in six-well tissue culture plates were
stimulated with PMA (10 ng/ml) and ionomycin (1 
 
m
 
g/ml) or
anti-CD3 immobilized on L–CD32-B7 transfectants for 5 h.
Monensin (3 
 
m
 
M; Biosource International) was added for 2 h be-
fore staining to prevent cytokine secretion. Cells were collected,
fixed, and intracellular cytokines were detected by flow cytome-
try using a commercial kit (IC Screen™; Biosource International)
with FITC-anti–IFN-
 
g
 
 mAb and PE-anti–IL-4 mAb (BD
PharMingen). Stained cells were analyzed using a FACScan™
(Becton Dickinson).
 
Quantitation of Cytokine Secretion by ELISA or RIA.
 
The
amounts of IL-12 p70 and TNF-
 
a
 
 in the culture supernatant of
activated iDCs were measured after 24 h by a two-site sandwich
ELISA as described (16). Anti–IL-12 mAbs were provided by M.
Gately (Hoffmann-La Roche). In T cell cultures, IL-2, IL-4, IL-5,
IL-13, and IFN-
 
g
 
 measurements were determined using ELISA
or RIA as described (15).
 
Statistical Analysis. 
 
The Student’s paired 
 
t 
 
test was used to
determine statistical significance of the data. 
 
*
 
P 
 
, 
 
0.05; 
 
**
 
P 
 
,
 
0.01; 
 
***
 
P 
 
, 
 
0.001.
 
Results
 
IL-12 p70 and TNF-
 
a
 
 Release by Activated Myeloid DCs.
 
Peripheral blood monocytes were differentiated into iDCs
after culturing with GM-CSF and IL-4. Stimulation for
24 h with different bacterial products or L-CD40L transfec-
tants induced the release of large amounts of IL-12 p70 and
TNF-
 
a
 
 (Fig. 1); the lowest levels were secreted after LPS or
Figure 1. Cytokine production by activated my-
eloid DCs. IL-12 p70 and TNF-a secretion after
24 h activation of iDC with the indicated stimuli.
Results are the mean values 6 SEM of at least three
independent experiments. The number of separate
experiments is indicated in parenthesis. 
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CD40L stimulation. Note that IFN-
 
g
 
, added during the cul-
ture together with, or 1 d before, the stimulus (
 
g
 
-primed LPS)
significantly enhanced cytokine release (
 
P
 
 , 
 
0.05). Activation
of iDCs with TNF-
 
a
 
 and IL-1-
 
a
 
 gave similar cytokine levels
as LPS stimulation (not shown). The nature of the activating
signals did not influence the phenotype of mDC (DC
 
1
 
) that
expressed high levels of CD83, CD40, CD80, CD86, and
MHC class II (Tanaka, H., personal observations).
 
Human DC
 
1
 
 Promote the Differentiation of Naive T Cells into
Th2 at 1:300 Stimulator/Responder Ratio.
 
We next evalu-
ated the nature of secondary allogeneic T cell responses
stimulated by iDCs or mDCs differentiated with bacterial
(SAC, IFN-
 
g
 
–primed LPS) or T cell–dependent (CD40L)
signals. Umbilical naive CD4
 
1
 
CD45RA
 
1
 
 T cells were
cocultured for 4 d with DCs at stimulator/responder ratios
of 1:4 and 1:300. After 7–10 d of expansion in IL-2 (50
U/ml), cells were washed, counted, and restimulated with
either anti-CD3 immobilized on L-CD32/B7 transfectants
or PMA and ionomycin (Fig. 2). Naive CD4
 
1
 
 T cells co-
cultured at low ratio (1:300) in primary MLR with mDCs
differentiated with SAC or CD40L signals differentiated
into typical Th2 cells producing large quantities of IL-4 (up
to 1.7 ng/ml) (compared with activated T cells primed
with iDCs) and releasing very small amounts of IFN-
 
g
 
(Fig. 2 A). Similar results were obtained with naive T cells
cocultured at 1:300 ratio with LPS, TNF-
 
a
 
 plus IL-1, or
SAC plus IFN-
 
g
 
–activated mDCs (not shown). This strong
Th2 response was confirmed by flow cytometry since naive
T cells matured into single IL-4–producing cells (40–46%
positive cells) secreting no IFN-
 
g
 
 (
 
#
 
3% positive cells) (Fig.
2 B). Conversely, regardless of the nature of the DC stimu-
lation, a high stimulator/responder ratio (1:4) favored a
mixed Th1/Th2 response (IFN-
 
g
 
–positive cells ranging
from 13 to 23% and IL-4–positive cells from 23 to 29%)
(Fig. 2 B). Note that at 1:4 ratio, 
 
g
 
-primed LPS–activated
mDCs appeared to be the most effective APCs, when com-
pared with other mDCs, in triggering large amounts of
IFN-
 
g
 
 secretion in the culture supernatant of activated T
cells (Fig. 2 A). This correlated with the highest IL-12 pro-
duction by 
 
g
 
-LPS–activated DCs (Fig. 1). However, at
1:300 ratio, activated T cells mixed with 
 
g
 
-LPS mDCs re-
leased up to 1.3 ng/ml of IL-4 and low IFN-
 
g
 
 (Fig. 2 A).
To evaluate the role of the intermediate culture in IL-2
on T cell polarization, DC–T cell cocultures were per-
formed at 1:4 and 1:300 ratios for 6–7 d, washed, and 2.5 
 
3
 
10
 
5
 
 viable T cells were immediately restimulated on anti-
CD3 immobilized on L-CD32/B7 transfectants. As shown
in Table I, Th effectors differentiated in the absence of ex-
pansion in IL-2 secreted low but significant levels of cyto-
kines and displayed polarization profiles similar to those of
Th effectors obtained after expansion in IL-2, namely Th2
at 1:300 and mixed Th1/Th2 at 1:4 ratio. Note that the re-
covery of allospecific T cells was drastically increased (10–
25-fold) after expansion in IL-2 and consistently higher (2–
4-fold) at 1:4 than 1:300 ratio (Tanaka, H., unpublished
observations). Similarly, the number of activated T cells at
the end of MLR was higher at 1:4 than 1:300 ratio (%
CD25
 
1 
 
cells: 66.1% 
 
6 
 
13 at 1:4 and 38.5%
 
 6 
 
3.1 at 1:300).
To further confirm the polarization of the response to-
ward Th2 at 1:300 ratio, we showed that primed T cells
also secreted large amounts of IL-5 (10–15 ng/ml) and IL-
10 (
 
z
 
1 ng/ml) (Fig. 3). The production of IL-13, a non-
typical Th2 cytokine in humans, was induced in both cul-
ture conditions, albeit at a higher level at 1:300 ratio,
whereas IL-2 level was not influenced by the cellular ratio.
In agreement with Cella et al. (11), iDCs were much less
efficient than mDCs in stimulating T cell proliferation and
induced at both cellular ratios a mixed Th1/Th2 cytokine
profile as determined at the single cell level (Tanaka, H.,
personal observations). However, as shown in Fig. 2 A,
iDC were poor inducers of Th2 cytokine release, except
Figure 2. Myeloid DC promotes Th2 development at 1:300 DC/T ra-
tio and favors Th1/Th2 at 1:4 ratio. Human naive CD41 T cells were
cocultured for 4 d with allogeneic mDCs at low (1:300) or high (1:4)
stimulator/responder ratio. After IL-2 expansion, T cells were counted
and restimulated with anti-CD3 immobilized on L-CD32/B7 transfec-
tants (A) or with PMA and ionomycin for 5 h (B). (A) IL-4 and IFN-g
were measured in 24- or 48-h culture supernatant, respectively, by ELISA
or RIA. Data are the mean values of at least four experiments 6 SEM
(statistical analysis, *mDCs vs. immature DCs, †g-LPS vs. other mDCs).
Similar results were obtained after PMA and ionomycin stimulation. (B)
104 cells were analyzed by flow cytometry for IL-4 and IFN-g expression,
and the percentage of positive cells is indicated in the quadrants. Data are
one experiment representative of two independent experiments.408 Human Myeloid Dendritic Cells Induce Th2 or Th1 Differentiation
for IL-10 and iDC-primed T cells that released large
amounts of IFN-g at 1:4 ratio, which correlated with high
levels of IFN-g during primary MLR (not shown).
Th2 Differentiation Is Dependent on B7–CD28 Costimula-
tion and OX40–OX40L Interactions. IL-12, a cytokine
produced by APCs, skews differentiation towards a Th1 re-
sponse whereas the Th2-driven response is usually IL-4 de-
pendent (18). Although the precise source of IL-4 in the
initiation of a Th2 response is a controversial issue,
NK1.11 cells and naive T cells are good candidates (4, 19).
The induction of Th2 effectors by mDCs at 1:300 ratio was
not affected by the presence of a combination of neutraliz-
ing anti–IL-4 and anti–IL-4R Abs in primary MLR as
shown by intracytoplasmic staining (Fig. 4 A) or by ELISA
(Tanaka, H., personal observations). The same Abs com-
pletely suppressed IL-4–induced CD23 expression by PBMCs
(not shown). However, cytolytic T lymphocyte–associated
Ag (CTLA)-4–Fc, added during primary culture, reduced
by z50% the number of IL-4–producing cells (Fig. 4 B)
and by z80% IL-4 and IL-5 release in the culture superna-
tant of activated T cells with no increase in IFN-g secre-
tion (Fig. 4, B and C). In agreement with our previous
studies (15), anti-OX40L mAb, added at priming, signifi-
cantly suppressed IL-4 and IL-5 production at restimula-
tion (Fig. 4 C). Interestingly, CD40–CD40L interac-
tions  did not appear to be critical for Th2 development and
IL-2 production was not significantly affected under the
above culture conditions (Fig. 4 C). Also shown in Fig. 4
and in agreement with other studies (9, 11), anti–IL-12
mAb strongly inhibited at 1:4 ratio the development of
IFN-g–producing cells (Fig. 4 A) and IFN-g secretion (not
shown) whereas CTLA-4–Fc favored immune deviation
towards Th1 effectors (Fig. 4 B).
Discussion
Our results revealed that Th2 differentiation of human
naive T cells could be elicited by myeloid-derived DC1 and
was largely dependent on a low (1:300) DC/T cell ratio
during primary MLR, demonstrating that Th2-driven re-
sponses are not restricted to the human DC2 lineage (9).
To increase the recovery of allospecific T cells, we per-
formed an intermediate culture in IL-2. Note that Th ef-
fectors displayed a similar cytokine profile in the absence
(Table I) or presence (Fig. 2 A) of expansion in IL-2. In
support of our data that high (1:4) DC1/T cell ratio favored
a Th1 cytokine profile, Rissoan et al. (9) have used 1:2, 1:4,
and 1:8 myeloid (DC1)–naive T cells cocultures, with no
expansion in IL-2, to generate Th1 effectors. Also, Cella et
al. (11) reported that freshly isolated plasmacytoid DC2 in-
duced both type 1 and type 2 helper T cells. Taken to-
gether, these data do not support an exclusive role of DC1
for induction of Th1 cells and of DC2 for Th2.
Th2 development depends on the route of immuniza-
tion, the nature and the concentration of Ag, and the bal-
ance between IL-4 and IL-12 at priming (4, 19). At 1:300
DC/T ratio, alloantigen and IL-12 were present in low
quantities and these two conditions reportedly favored a
Th2 response. Our results further indicated that a combina-
tion of neutralizing anti–IL-4 and anti–IL-4 receptor Abs
did not impair the initiation of the Th2 response. Although
we cannot completely exclude the presence of residual IL-4,
an IL-4–independent generation of Th2 effectors was re-
ported after naive T cells stimulation by low doses of Ag
(20) or by plasmacytoid DCs (9), without yet identifying
the surface molecules possibly involved during DC–T in-
teractions. Here we show that at 1:300, B7/CD28–CTLA-4
Table I. Human DC1 Promotes Th2 versus Th1 Effectors in the 
Absence of IL-2 Expansion
Ratio IFN-g IL-4
Experiment 1 1:4 2.8 0.2
1:300 0.5 0.7
Experiment 2 1:4 3.8 0.15
1:300 0.6 0.54
Experiment 3 1:4 2.0 0.1
1:300 0.2 0.46
Naive T cells (106/ml) were stimulated for 6–7 d with mDCs activated 
by L-CD40L transfectants (Experiment 1 or 2) or SAC (Experiment 3) 
at 1:4 and 1:300 ratio. After washing, cells were restimulated with anti-
CD3 immobilized on L-CD32/B7.1 L transfectants. Cytokines (in ng/
ml) were measured after 24 h.
Figure 3. Cytokine profile of effectors primed at 1:4 and 1:300 ratios.
Human naive CD41 T cells were cocultured for 4 d with allogeneic iDCs
or mDCs at low and high density ratio, expanded in IL-2, and restimu-
lated with anti-CD3 immobilized on L-CD32/B7 transfectants. IL-2, IL-5,
IL-10, and IL-13 were measured by ELISA or RIA in culture superna-
tants after 24 h (reference 15). Data are the mean values 6 SEM of at least
four independent experiments.409 Tanaka et al.
blockade by CTLA-4–Fc prevented differentiation of naive
T cells into Th2 with no immune deviation towards Th1.
Several reports indicated that CD28 influences Th2 differ-
entiation (21–25). Engagement of CD28 by B7 molecules
promotes Th2 development, whereas CTLA-4 is a potent
inhibitor of the Th2 differentiation pathway (21). We pre-
viously reported that CD3 and CD28 costimulation of pu-
rified human naive CD41 T cells induced IL-4 production
at priming and at restimulation, skewing the cytokine pro-
file towards Th2 (22). These results are in keeping with
Kalinski et al. (23) and King et al. (24) but are in apparent
contradiction with Rissoan et al. (9). CD41 T cells in
CTLA-4–deficient mice secreted high levels of IL-4 and
IL-5 upon TCR activation and anti-CD28 costimulation
compared with wild-type T cells (25). CD28 costimulation
increased IL-4R sensitivity by enhancing phosphorylation
of Janus kinase 3 (Jak3), the IL-4Ra chain, and signal
transducer and activator of transcription 6 (STAT-6) after
IL-4 stimulation (26). Finally and in support of our data,
the B7/CD28–CTLA-4 costimulatory pathway plays a role
in the pathogenesis of allergen-induced airway hyperre-
sponsiveness in a murine model of allergic asthma (27). Ad-
Figure 4. Th2 differentiation is dependent on B7–CD28 costimulation and
OX40–OX40L interactions. Human naive CD41 T cells were cocultured with
allogeneic mDCs at different stimulator/responder ratios in the presence of con-
trol Ab, anti–IL-12 mAb (10 mg/ml), or anti–IL-4 plus anti–IL-4R Abs (5 mg/ml
each) (A), and NHIg-Fc or CTLA-4–FC (5 mg/ml) (B). After IL-2 expansion, T
cells were counted and restimulated with PMA and ionomycin for 5 h and
stained as in the legend to Fig. 2. Data are representative of at least two indepen-
dent experiments. (C) Naive T cells were cocultured with SAC-activated alloge-
neic DCs at 1:300 ratio in the presence of anti-CD40L, anti-OX40L, respective
control mAbs (10 mg/ml) (IgG2a or IgG1), NHIg-Fc, or CTLA-4–Fc (5 mg/ml).
After IL-2 expansion, T cells were restimulated with anti-CD3 immobilized on
L-CD32/B7 transfectants. After 24–48 h, cytokine release was measured as in the
legends to Figs. 2 and 3. Data are the mean values 6 SEM of at least four inde-
pendent experiments.410 Human Myeloid Dendritic Cells Induce Th2 or Th1 Differentiation
ministration of CTLA-4–Ig before Ag sensitization de-
creased airway hyperresponsiveness and IL-4 production in
the bronchoalveolar lavage with no change in IFN-g. Be-
sides B7/CD28 molecules, other costimulatory interac-
tions, including CD40–CD154, RANK–RANKL, and
OX40–OX40L, have an important role in DC–T cell in-
teractions (28). In the present study, we confirmed and ex-
tended with different mDCs our previous observations that
blocking OX40–OX40L interactions inhibited Th2 devel-
opment (15). In vivo studies confirmed the involvement of
the OX40–OX40L pathway in DC–T cell interactions but
its differential role in Th2 versus Th1 varies according to
the in vivo models (28, 29).
iDCs, widely distributed in nonlymphoid tissues, are
specialized in Ag capture, but a fundamental function of
these cells is their capacity to migrate (5, 30). The rate of
DC migration from blood to tissues and tissues to lymph
nodes is considerably increased by inflammatory stimuli
(30–33). Systemic administration of LPS or TNF-a re-
sulted in a drastic decrease of DCs from the peripheral tis-
sues or marginal zone of the spleen followed by transient
accumulation of mDCs in the T cell zones (31–34). Differ-
ent inflammatory chemokines and chemokine receptors se-
creted or expressed by DCs and endothelial cells partici-
pated in each step of DC migration (30, 35). The migratory
and stimulatory DCs recruited under inflammatory condi-
tions are myeloid derived whereas resident lymphoid DCs
may be responsible for induction of tolerance in the ab-
sence of inflammation (30). The current concept is that,
besides the nature of the DCs, the quantity and the quality
of the costimulatory molecules and cytokines they express
determine the balance between Th1 and Th2 effector cells
that will be generated (36). Our results further suggest that
the ratio between mature myeloid DCs and naive T cells
appears as important to polarize the immune response.
Therefore, finding factors and understanding the mecha-
nisms that regulate the rate and the number of DCs that
migrate from skin, mucosa, and interstitial tissues to their
final destination in the T cell areas will be relevant for
opening new avenues for therapeutic intervention (37).
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